Tissue oxygenation and hemodynamic response to no synthase inhibition in septic shock

Shock

Volumn 14, Issue 1, 2000, Pages 35-40

  Broccard, Alain ^a   Hurni, Jean Marc ^a   Eckert, Philippe ^a   Liaudet, Lucas ^a   Schaller, Marie Denise ^a   Lazor, Romain ^a   Perret, Claude ^a   Feihl, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adrenergic support; Blood pressure; Cardiac output; Gastric tonometry; Human; L NAME; L NMMA; Nitric oxide; Oxygen consumption; Septic shock

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CELL HYPOXIA; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT OUTCOME;

ADRENERGIC AGONISTS; ADULT; AGED; CELL HYPOXIA; DRUG EVALUATION; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 0034222910     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014010-00007     Document Type: Article

References (40)

1. Parillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
2. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol 259: H1038-H1043, 1990.
3. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132-1138, 1990.
4. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: how much in beneficial? Lancet 338: 1555-1557, 1991.
5. Moncada S, Higgs EA: Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21: 361-374, 1991.
6. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214: 621-626, 1991.
7. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula M, Moncada S: L-arginine: nitric oxide pathway in endotoxemia. Crit Care Med 23: 253-258, 1995.
8. Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL: An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27: 913-22, 1999.
9. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-999, 1989.
10. Kilbourn RG, Traber DL, Szabo C: Nitric oxide and shock. Dis Mon 43: 277-348, 1997.
11. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557-1558, 1991.
12. Geroulanos S, Schilling J, Cakmakci M, Jung HH, Largiader F: Inhibition of NO synthesis in septic shock (letter). Lancet 339: 435, 1992.
13. Lorente JA, Landin L, De Pablo R, Renes E, Liste D: L-arginine pathway in the sepsis syndrome. Crit. Care Med. 21: 1287-1295, 1993.
14. Lin PJ, Chang CH, Chang JP: Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase. Chest 106: 626-629, 1994.
15. Locker GJ, Burgmann H, Staudinger T, Knapp S, Laczika KF, Frass M: Fatal cardiac side effects of L-NMMA? [letter] . Crit. Care Med. 24: 1930, 1996.
16. Kilbourn RG, Fonseca GA, Griffith OW, Ewer M, Price K, Striegel A, Jones E, Logothetis CJ: NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension. Crit. Care Med. 23: 10181024, 1995.
17. Kiehl MG, Ostermann H, Meyer J, Kienast J: Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med. 23: 561-566, 1997.
18. Avontuur JA, Tutein Nolthenius RP, Buijk SL, Kanhai KJ, Bruining HA: Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Chest 113: 1640-1646, 1998.
19. Avontuur JAM, Stam TC, Jongen-Lavrencic M, van Amsterdam JGC, Eggermont MM, Bruining HA: Effect of L-NAME, an inhibitor of nitric oxide synthesis on plasma levels of IL-6, IL-8, TNFα, and nitrite/nitrate in human septic shock. Intensive Care Med. 24: 673-679, 1998.
20. Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study [see comments]. Crit. Care Med. 26: 660-667, 1998.
21. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39, 1994.
22. Grover R, Bakker J, McLuckie A, Anderson J, LeGall JR: The nitric oxide synthase inhibitor 546C88 promotes the resolution of shock in patients with sepsis. Crit. Care Med. 26: A29 [Abstract], 1998.
23. Russell JA: Gastric tonometry: does it work? [editorial]. Intensive Care Med. 23: 3-6, 1997.
24. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C: Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am. J. Resp. Crit. Care Med. 150: 324-329, 1994.
25. 2 is an important source of error in the assessment of gastric intramucosal pH. Crit. Care Med. 22: 1877-1879, 1994.
26. Winer BJ: Statistical principles in experimental design. New York. McGraw-Hill. 1971. 172-175.
27. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. [Review], Shock 7: 235-246, 1997.
28. Parratt JR: Nitric oxide in sepsis and endotoxaemia. J. Antimicrob. Chemother. 41 Suppl A: 31-39, 1998.
29. Moncada S, Higgs EA: The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
30. Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempé JD: Methylene blue increases systemic vascular resistance in human septic shock. Intensive Care Med. 18: 309-311, 1992.
31. Preiser JC, Lejeune P, Romand A, Carlier E, De Backer D, Leeman M, Kahn RJ, Vincent JL: Methylene blue administration in septic shock: a clinical trial. Crit. Care Med. 23: 259-264, 1995.
32. Daemen-Gubbels CR, Groeneveld PH, Groeneveld AB, van Kamp GJ, Bronsveld W, Thijs LG: Methylene blue increases myocardial function in septic shock. Crit. Care Med. 23: 1363-1370, 1995.
33. Gachot B, Bedos JP, Veber B, Wolff M, Regnier B: Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock. Intensive Care Med. 21: 1027-1031, 1995.
34. Stock MC, Ryan ME: Oxygen consumption calculated from the Fick equation has limited utility . Crit. Care Med. 24: 86-90, 1996.
35. Weissman C, Kemper M, Elwyn DH, Askanazi J, Hyman AI, Kinney JM: The energy expenditure of the mechanically ventilated critically ill patient. Chest 89: 254-259, 1986.
36. 2 in endotoxemic dogs during shock and resuscitation. J Appl. Physiol. 76: 793-800, 1994.
37. Ronco JJ, Fenwick JC, Wiggs BR, Phang PT, Russell JA, Tweeddale MG: Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am. Rev. Resp. Dis. 147: 25-31, 1993.
38. Ronco JJ, Fenwick JC, Tweeddale MG, Wiggs BR, Phang PT, Cooper DJ, Cunningham KF, Russell JA, Walley KR: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic patients. JAMA 270: 1724-1730, 1993.
39. D'Orio V, Mendes P, Carlier P, Fatemi M, Marcelle R. Lung fluid dynamics and supply dependency of oxygen uptake during experimental endotoxic shock and volume resuscitation. Crit. Care Med. 19: 955-962, 1991.
40. Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F: Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. Journal of Infectious Diseases 177: 127-132, 1998.